Health (Assisted Human Reproduction) Act 2024
|
PART 6 Pre-Implantation Genetic Testing | ||
|
Definitions - Part 6 | ||
|
44. In this Part— | ||
“AHR treatment to which this Part applies” means— | ||
(a) PGT, | ||
(b) HLA matching, and | ||
(c) sex selection; | ||
“genetic counselling”, in relation to AHR treatment to which this Part applies, means a service provided by a genetic counsellor, with clinical governance provided by a relevant specialist in any case where the genetic counsellor is not also a relevant specialist, under which he or she counsels a person regarding— | ||
(a) the potential risks and implications arising from and after the provision of such treatment, and | ||
(b) other options (if any) available in lieu of such treatment; | ||
“genetic counsellor”, in relation to AHR treatment to which this Part applies, means a person who has the requisite skills and judgment to provide genetic counselling as regards such treatment by virtue of— | ||
(a) holding a qualification prescribed (following, on and after the establishment day, consultation by the Minister with the AHRRA) for the purposes of this definition, | ||
(b) having the practical experience prescribed (following, on and after the establishment day, consultation by the Minister with the AHRRA) for the purposes of this definition, or | ||
(c) holding a qualification, and having the practical experience, prescribed (following, on and after the establishment day, consultation by the Minister with the AHRRA) for the purposes of this definition; | ||
“genetic disease” means a disease caused by single gene or chromosomal variants that can be inherited and that, on the basis of existing scientific and medical evidence, confers a high risk on the person with the disease of having— | ||
(a) a serious physical or intellectual disability, | ||
(b) a serious illness, or | ||
(c) a fatal condition; | ||
“HLA matching” means an AHR treatment using PGT to test and select an embryo for implantation in the womb of a woman for the purpose of matching the tissue of a child who is born as a result of the treatment with the tissue of an existing child who has a life limiting condition; | ||
“PGT” means pre-implantation genetic testing; | ||
“PGT-A” means PGT which falls within paragraph (a) of the definition of “pre implantation genetic testing”; | ||
“PGT-M” means PGT which falls within paragraph (b) of the definition of “pre implantation genetic testing”; | ||
“PGT-SR” means PGT which falls within paragraph (c) of the definition of “pre implantation genetic testing”; | ||
“pre-implantation genetic testing” means a test performed to analyse the DNA (deoxyribonucleic acid) of embryos for the purpose of determining genetic disorders, or for the undertaking of HLA matching, and includes— | ||
(a) such testing for aneuploidies (being embryos with an unbalanced chromosomal complement), | ||
(b) such testing for single gene disorders, | ||
(c) such testing for chromosomal structural rearrangements, and | ||
(d) such other testing prescribed (following, on and after the establishment day, consultation by the Minister with the AHRRA) for the purposes of this definition; | ||
“Register of Genetic Diseases” shall be construed in accordance with section 49 ; | ||
“relevant specialist” means a registered medical practitioner whose name is entered, in respect of clinical genetics, in the Specialist Division of the register of medical practitioners maintained by the Medical Council under section 43(2)(b) of the Act of 2007; | ||
“sex selection” means AHR treatment provided to a person for the purpose of ensuring, or increasing the probability, that an embryo will be of a particular sex; | ||
“variant” means a permanent change to the DNA sequence that makes up a gene that may cause disease or be part of normal human variation. |